Basel, 04 July 2017 Invitation to Roche Analyst Event on Diagnostics Division at AACC 2017 Tuesday, 1st August 2017, 6:00pm PDT We are pleased to invite you to an analyst event on Tuesday, 1st August 2017 to discuss Roche’s Diagnostics Division, in conjunction with the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical... Read more
July 4, 2017 Differentiates between HIV-1 and HIV-2 infections to confidently treat patients based on HIV subtype infection Significant reduction in time to detection is critical in curbing further disease transmission Access to testing in rural areas through validated dried blood spot (DBS) collection card Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial... Read more
Basel, 03 July 2017 Roche expands cobas Liat PCR System menu with launch of cobas MRSA/SA test to target healthcare-associated infections With more than 150,000 affected patients per year, MRSA and SA are major sources of healthcare and community associated infections in Europe Fast detection reduces the risk of transmission within the hospital, but classical... Read more
The AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system has been approved by the China Food and Drug Administration (CFDA) and meets the market access requirements for medical device products. 1 June 29, 2017 Shanghai, China — SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit that meets the newly published guidelines for evaluation of colorectal cancer from the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology... Read more
16th FMF World Congress in Fetal Medicine, Ljubljana, Slovenia – June 28, 2017 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the publication of the Fetal Medicine Foundation’s (FMF’s) Project “ASPRE”study results in The New England Journal of Medicine. These compelling findings revealed that administering low-dose aspirin (150... Read more
Basel, 23 June 2017 Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously untreated follicular lymphoma Longer follow-up showed sustained benefit in progression-free survival of Gazyva/Gazyvaro-based treatment over MabThera/Rituxan-based treatment regardless of chemotherapy regimens People with follicular lymphoma who received Gazyva/Gazyvaro-based treatment reported improvement in health-related quality of... Read more
June 22, 2017 – Saluggia, Italy; Hilden, Germany, and Germantown, Maryland – DiaSorin (FTSE Italy Mid Cap: DIA) and QIAGEN (NASDAQ: QGEN; Frankfurt Stock Exchange: QIA) announced today a new collaboration to develop new tests for DiaSorin’s LIAISON family of analyzers based on a review and selection process involving QIAGEN’s assay technologies. The adoption of... Read more
Gold-standard test for latent tuberculosis infection will be covered by national health insurance Hilden, Germany, and Paris, France, June 22, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that France’s Ministry of Health and Social Affairs has approved reimbursement by the national health insurance system for QIAGEN’s QuantiFERON-TB® Gold Plus (QFT-Plus®)... Read more
MOU signed between Mexico SAGARPA’s INIFAP and Seegene for collaborative product development and clinical study: (from middle to left) INIFAP’s bovine TB Director Dr. Ferando Otero, Head of Seegene Institute of Life Sciences Dr. Nackmoon … SEOUL, South Korea, June 21, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered... Read more